Table 3.
Disease type | Total (N = 114) |
CHF (n = 35) |
Stroke (n = 21) |
ESRD (n = 28) |
ESLD (n = 30) |
F or χ2(p) |
---|---|---|---|---|---|---|
Variables | M ± SD/n (%) | M ± SD/n (%) | M ± SD/n (%) | M ± SD/n (%) | M ± SD/n (%) | |
Anxiety (0–21) | 7.48 ± 3.60 | 7.40 ± 3.29 | 7.14 ± 4.05 | 7.36 ± 3.81 | 7.91 ± 3.56 |
0.216 (0.885) |
Normal (0–7) | 57 (50.0) | 15 (42.9) | 13 (61.9) | 12 (42.9) | 17 (56.7) |
8.029 (0.241) |
Borderline (8–10) | 37 (32.5) | 16 (45.7) | 3 (14.3) | 11(39.3) | 7 (23.3) | |
Abnormal (11–21) | 20 (17.5) | 4 (11.4) | 5 (23.8) | 5 (17.9) | 6 (20.0) | |
Depression (0–21) | 9.17 ± 3.71 | 9.17 ± 3.71 | 9.43 ± 3.61 | 9.57 ± 3.63 | 8.62 ± 3.54 |
0.359 (0.783) |
Normal (0–7) | 36 (31.9) | 8 (22.9) | 6 (28.6) | 9 (32.1) | 13 (44.8) |
5.949 (0.438) |
Borderline (8–10) | 35 (31.0) | 15 (42.9) | 5 (23.8) | 8 (28.6) | 7 (24.1) | |
Abnormal (11–21) | 42 (37.2) | 12 (34.3) | 10 (47.6) | 11 (39.3) | 9 (31.0) |
M mean, SD standard deviation, CHF chronic heart failure, ESRD end-stage renal disease, ESLD end-stage liver disease